• About Us
    • Company History
    • Our Mission
    • Management Team
    • Board of Directors
  • Technology
    • The Problem
    • The Solution: Our Microbial Platforms
      • C1
      • Dapibus™
    • Advantages and Opportunities
  • Pipeline
    • Human Health
    • Animal Health
    • Alternative Proteins
  • Partners
  • Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Financials
    • Investor Fact Sheet
    • Analyst Coverage
    • Corporate Governance
    • Annual Meeting and Proxy
    • Stock Information
    • Earnings Calls
    • Email Alert Opt-in
  • Media
    • Articles
    • Events
    • Presentations
    • Press Releases
    • Scientific Publications
    • Video Gallery
  • Contact Us

Science

Recent Posts

  • Dyadic to Participate at Upcoming Events in June
  • Dyadic Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
  • Dyadic to Participate at Two Industry Events in May
  • Dyadic Announces Collaboration to Commercialize Animal-Free Alternative Proteins Using Dapibus™
  • Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023

Recent Comments

No comments to show.

Sign up for communications from Dyadic

Stay informed and receive company updates straight to your inbox.

Signup

Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical and bio-industrial products for human and animal health and alternative proteins.

  • About Us
    • Company History
    • Our Mission
    • Management Team
    • Board of Directors
  • Technology
    • The Problem
    • The Solution: Our Microbial Platforms
      • C1
      • Dapibus™
    • Advantages and Opportunities
  • Pipeline
    • Human Health
    • Animal Health
    • Alternative Proteins
  • Partners
  • Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Financials
    • Investor Fact Sheet
    • Analyst Coverage
    • Corporate Governance
    • Annual Meeting and Proxy
    • Stock Information
    • Earnings Calls
    • Email Alert Opt-in
  • Media
    • Articles
    • Events
    • Presentations
    • Press Releases
    • Scientific Publications
    • Video Gallery
  • Contact Us
© 2023 Dyadic International Inc